A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Podrobná bibliografie
Hlavní autor:	Islam, Saidul
Další autoři:	Sharmin, Shahana
Médium:	Diplomová práce
Jazyk:	English
Vydáno:	Brac University 2022
Témata:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
On-line přístup:	http://hdl.handle.net/10361/17308

Podobné jednotky

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
Autor: Karim, Azrin
Vydáno: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Autor: Flora, Sanzida Alam
Vydáno: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Autor: Meem, Manila
Vydáno: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
Autor: Alam, Tahera
Vydáno: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
Autor: Jahan, Nusrat
Vydáno: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
Autor: Ahmed, Nafisa
Vydáno: (2023)

Immunotherapy in the Management of Lung Cancer
Autor: Tasnim, Humayra
Vydáno: (2022)

A review on triple-negative breast cancer and its potential treatment
Autor: Niasa, Jannatul Ferdous
Vydáno: (2023)

Stem cells as therapeutic carrier in cancer treatment
Autor: Anika, Mysha Yeasmin
Vydáno: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
Autor: Hasan, Amit
Vydáno: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Autor: Chakraborty, Anuradha
Vydáno: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Autor: Khan, Muidul Hasan
Vydáno: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
Autor: Roy, Hredita
Vydáno: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
Autor: Emon, Kamrul Hasan
Vydáno: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
Autor: Mirza, Maisa Tasnim
Vydáno: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
Autor: Khan, Rezia Nowrin
Vydáno: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
Autor: Nuha, Nabiha Tahsin
Vydáno: (2024)

Role of statins as antagonists of SPARC in gastric cancer
Autor: Shahmat, Rad
Vydáno: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
Autor: Sorno, Rubina Haque
Vydáno: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Autor: Ratu, Tabassum
Vydáno: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
Autor: Choki, Kinley
Vydáno: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Autor: Razna, Amrin Islam
Vydáno: (2019)

A comprehensive review on drug repurposing in cancer treatment
Autor: Sarkar, Onusree
Vydáno: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
Autor: Mahaleka, Aarshi
Vydáno: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
Autor: Shaikat, Mahdi Mubin
Vydáno: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
Autor: Hasan, Sakib
Vydáno: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
Autor: Nawar, Anika
Vydáno: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
Autor: Deeba, Maliha Tasnim
Vydáno: (2018)

Targeting BRAFV600E in the treatment of CRC
Autor: Roja, Mashwiyat Samrin
Vydáno: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
Autor: Alam, Kazi Tasnuva
Vydáno: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
Autor: Rahman, Sanjida
Vydáno: (2024)

Biosimilar in lymphoma treatment
Autor: Tanisha, Mehrin Haque
Vydáno: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
Autor: Khondokar, Faiza
Vydáno: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
Autor: Islam, Nahidul
Vydáno: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
Autor: Beruni, Sajid Mahmud Al
Vydáno: (2022)

Oncogenes: new targets in cancer treatment
Autor: Chowdhury, Waseka Shams
Vydáno: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
Autor: Muntaha, Habibatul
Vydáno: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
Autor: Haque, Mushfiqul
Vydáno: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Autor: Karim, Samia Binte
Vydáno: (2024)